Quanta Receives FDA 510(k) Clearance for the SC+ Hemodialysis System Setting the Stage for US Market Launch

by NASDAQ Market News January 8, 2021

NASDAQ Market News
Click here to email author

Myriad Genetics Receives First Reimbursement Decision for myChoice® Diagnostic System in Japan, Enabling Women with Ovarian Cancer to Benefit from Treatment with Zejula®

Chimerix Acquires Oncoceutics to Expand Pipeline with Late-Stage Oncology Program

Ads